Amplify Surgical marked the milestone of treating 500 spinal levels with the dualX® Expanding Interbody Fusion System. This is an increase from 300 treated levels as reported in March 2020.
dualX titanium devices expand in both width and height, and are implanted in lateral lumbar interbody fusion (LLIF), posterior lumbar interbody fusion (PLIF) and transforaminal lumbar interbody fusion (TLIF) procedures. The portfolio contains varying footprints, heights and degrees of lordosis, with post-expansion bone grafting.
Andy Choi, Amplify Surgical CEO, said, “During these unprecedented times, I am very pleased to see continued growth and strong adoption in new regions of the country. We are extremely thankful to have such an incredible group of surgeons to work with as we continue to develop and commercialize the dualX technology.”
Amplify Surgical marked the milestone of treating 500 spinal levels with the dualX® Expanding Interbody Fusion System. This is an increase from 300 treated levels as reported in March 2020.
dualX titanium devices expand in both width and height, and are implanted in lateral lumbar interbody fusion (LLIF), posterior lumbar interbody fusion...
Amplify Surgical marked the milestone of treating 500 spinal levels with the dualX® Expanding Interbody Fusion System. This is an increase from 300 treated levels as reported in March 2020.
dualX titanium devices expand in both width and height, and are implanted in lateral lumbar interbody fusion (LLIF), posterior lumbar interbody fusion (PLIF) and transforaminal lumbar interbody fusion (TLIF) procedures. The portfolio contains varying footprints, heights and degrees of lordosis, with post-expansion bone grafting.
Andy Choi, Amplify Surgical CEO, said, “During these unprecedented times, I am very pleased to see continued growth and strong adoption in new regions of the country. We are extremely thankful to have such an incredible group of surgeons to work with as we continue to develop and commercialize the dualX technology.”
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Copy to clipboard 
